Insider Selling: Aveanna Healthcare (NASDAQ:AVAH) Director Sells $2,070,000.00 in Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Director Rodney Windley sold 180,000 shares of the business’s stock in a transaction on Thursday, August 20th. The stock was sold at an average price of $11.50, for a total transaction of $2,070,000.00. Following the completion of the sale, the director owned 2,078,017 shares of the company’s stock, valued at $23,897,195.50. The trade was a 7.97% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.

Aveanna Healthcare Price Performance

NASDAQ AVAH opened at $13.62 on Thursday. Aveanna Healthcare Holdings Inc. has a 1 year low of $5.93 and a 1 year high of $13.98. The company has a fifty day simple moving average of $9.95 and a 200 day simple moving average of $8.03. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 4.47. The company has a market cap of $2.97 billion, a P/E ratio of 11.07, a P/E/G ratio of 0.85 and a beta of 1.90.

Aveanna Healthcare (NASDAQ:AVAH) last announced its earnings results on Thursday, August 13th. The company reported $0.22 EPS for the quarter, topping the consensus estimate of $0.17 by $0.05. The firm had revenue of $670.48 million for the quarter, compared to the consensus estimate of $638.61 million. Aveanna Healthcare had a net margin of 10.56% and a return on equity of 80.70%. On average, sell-side analysts predict that Aveanna Healthcare Holdings Inc. will post 0.75 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Vanguard Group Inc. grew its position in Aveanna Healthcare by 38.0% during the fourth quarter. Vanguard Group Inc. now owns 5,577,010 shares of the company’s stock worth $45,564,000 after buying an additional 1,535,351 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in Aveanna Healthcare by 49.5% during the first quarter. Dimensional Fund Advisors LP now owns 1,334,374 shares of the company’s stock valued at $8,593,000 after acquiring an additional 441,707 shares during the period. Segall Bryant & Hamill LLC raised its holdings in Aveanna Healthcare by 425.8% in the 1st quarter. Segall Bryant & Hamill LLC now owns 163,966 shares of the company’s stock valued at $1,056,000 after acquiring an additional 132,779 shares in the last quarter. NFJ Investment Group LLC acquired a new position in Aveanna Healthcare in the 2nd quarter valued at approximately $2,682,000. Finally, Weiss Asset Management LP bought a new stake in shares of Aveanna Healthcare in the 1st quarter worth approximately $732,000. Institutional investors own 87.96% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on AVAH shares. BMO Capital Markets lifted their price objective on Aveanna Healthcare from $10.00 to $14.00 and gave the stock an “outperform” rating in a research note on Friday, August 14th. Weiss Ratings restated a “hold (c+)” rating on shares of Aveanna Healthcare in a research note on Thursday, July 2nd. Barclays raised their target price on Aveanna Healthcare from $9.00 to $9.50 and gave the company an “overweight” rating in a report on Thursday, July 9th. Royal Bank Of Canada lifted their price target on Aveanna Healthcare from $10.00 to $16.00 and gave the stock an “outperform” rating in a research report on Monday. Finally, Raymond James Financial upped their price target on Aveanna Healthcare from $13.00 to $15.00 and gave the stock a “strong-buy” rating in a report on Friday, August 14th. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat.com, Aveanna Healthcare has a consensus rating of “Moderate Buy” and an average target price of $12.89.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.